服务热线
15339069646服务热线
15339069646| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-B7H3/CD276;CD3E mAbs [Obrindatamab Biosimilar] (MABL-5004) | MABL-5004 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda |
| Anti-DLL3;CD3E mAbs [Obrixtamig Biosimilar] (MABL-5005) | MABL-5005 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-TSLP mAbs [Ocankitug Biosimilar] (MABL-5006) | MABL-5006 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MS4A1/CD20 mAbs [Ocaratuzumab Biosimilar] (MABL-5007) | MABL-5007 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Ociperlimab Biosimilar] (MABL-5008) | MABL-5008 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MS4A1/CD20 mAbs [Ocrelizumab Biosimilar] (MABL-5009) | MABL-5009 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Zaire Ebolavirus Glycoprotein mAbs [Odesivimab Biosimilar] (MABL-5010) | MABL-5010 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MS4A1/CD20;CD3E mAbs [Odronextamab Biosimilar] (MABL-5011) | MABL-5011 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-MS4A1/CD20 mAbs [Ofatumumab Biosimilar] (MABL-5012) | MABL-5012 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Ogalvibart Biosimilar] (MABL-5013) | MABL-5013 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDGFRA/CD140A mAbs [Olaratumab Biosimilar] (MABL-5014) | MABL-5014 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NT5E/CALJA/CD73 mAbs [Oleclumab Biosimilar] (MABL-5015) | MABL-5015 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-C5 mAbs [Olendalizumab Biosimilar] (MABL-5016) | MABL-5016 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-KAAG1/RU2AS mAbs [Olintatug Biosimilar] (MABL-5017) | MABL-5017 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CNR1/CB1 mAbs [Nimacimab Biosimilar] (MABL-4987) | MABL-4987 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-EGFR/ERBB1/HER1 mAbs [Nimotuzumab Biosimilar] (MABL-4988) | MABL-4988 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FCGRT/FcRn mAbs [Nipocalimab Biosimilar] (MABL-4989) | MABL-4989 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-Respiratory Syncytial Virus mAbs [Nirsevimab Biosimilar] (MABL-4990) | MABL-4990 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TGFB1/TGFB2 mAbs [Nisevokitug Biosimilar] (MABL-4991) | MABL-4991 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-GD2;CD3E mAbs [Nivatrotamab Biosimilar] (MABL-4992) | MABL-4992 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn